Adult

Nystatin

General Information

Antifungal

Restricted formulary antimicrobial: For details see OUH netFormulary

For all information regarding interactions, contraception, pregnancy and breastfeeding and additional information, see BNF and Summary of Product Characteristics (SPC).

Standard dose

100,000 units/mL oral suspension 1mL qds. Continue treatment for a further 2 days after lesions have healed  

Renal and hepatic impairment

Renal impairment

No dose adjustment required.

 

Hepatic impairment

No information available for use in hepatic impairment.

References

  1. Sandoz Limited. Summary of Product Characteristics. Nystatin Oral Suspension BP. Last revision of the text 29/7/2020. Accessed via https://www.medicines.org.uk/emc/product/4463/smpc#gref on 24/2/25
  2. The Renal Drug Database. Nystatin. Accessed via renaldrugdatabase.com on 24/2/25.
  3. BNF online accessed via www.medicinescomplete.com on 24/2/25

Editorial Information

Last reviewed: 03 Feb 2025

Next review date: 03 Feb 2028

Author(s): AMST.